google-site-verification: googlec7193c3de77668c9.html

A potential immunotherapy strategy for early-stage prostate cancer

[
Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically “cold,” meaning they do not attract enough immune cells to mount a strong attack. Hormone therapy commonly used for prostate cancer, called androgen deprivation therapy (ADT), can temporarily make tumors more responsive by drawing immune cells into the cancer. But that benefit is short-lived: the treatment also increases levels of regulatory T cells (Tregs), which act as brakes on the immune system and blunt its anticancer effects.


Source link

Advertisements
Views: 2

See also  Patients with rheumatoid arthritis have unique and complex autoantibody patterns, study reveals

Check Also

When healing injuries, timing of regenerative cues matters

[ Credit: Unsplash/CC0 Public Domain For decades, medicine has chased a simple but elusive goal …

Discovery could lead to drug therapy for hypopigmentation conditions

[ Ampyrone increases pigmentation in a human 3D epidermal model, The top row shows visible epidermal …

Watching live sports together boosts oxytocin and synchronizes heartbeats, study finds

[ Spectators cheer together during TSUKUBA LIVE!, the University of Tsukuba’s home-game initiative. The event …

Leave a Reply

Available for Amazon Prime